View Author
patient restenosi polymorphism study -10 factor netherland center stent haplotype effect analysis il -10 gene syndrome department leiden allele result association marrow cardiology trial block genotype intervention infusion bone marrow cells month level il -10 polymorphisms university intracoronary follow-up diabetes artery heart frequency plasminogen activator inhibitor signi table 298asp intracoronary infusion glu 298asp polymorphism vitamin nos 3 polymorphisms target vessel revascularization vdr gene -949 regression target population nitric il -10 event cell infusion monraat disease oxide nos 3 gene infarction procedure leiden university variant receptor percutaneou signi ficance function protein genotyping glu 298asp polymorphisms þ 4259 model -716 stent placement à1082 autologou synthase erasmus mc 2012-08-03 | id targets downloaded
7 Most Recent Publications
|
Stabilisation of atherosclerotic plaques position paper of the european society of cardiology (ESC) working group on atherosclerosis and vascular biology
(Article)
Ylä-Herttuala, S. Bentzon, J.F. Marx, N. Naruszewicz, M. Newby, A. Pasterkamp, G. Serruys, P.W.J.C. Waltenberger, J. Weber, C.A. Tokgözoglu, L. Daemen, M.J. Falk, E. Garcia-Garcia, H.M. Herrmann, J. Hoefer, I. Jukema, J.W. Krams, R. Kwak, B.R. |
2011-07-01
|
|
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial
(Article)
Duckers, H.J. Houtgraaf, J. Smits, P.C. Siminiak, T. Mieghem, W. van Legrand, V.M.G. Serruys, P.W.J.C. Hehrlein, C. Schofer, J. Waltenberger, J. Gershlick, A. Nienaber, C. Macaya Miguel, C.M. Bartunek, J. Peters, N.C. |
2011-02-01
|
|
Vitamin D receptor: A new risk marker for clinical restenosis after percutaneous coronary intervention
(Article)
Monraats, P.S. Fang, Y. Waltenberger, J. Frants, R.R. Quax, P.H.A. Laarse, A. van der Wall, E.E. van der Uitterlinden, A.G. Jukema, J.W. Pons, D. Pires, N.M.M. Pols, H.A.P. Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Dewinter, R.J. Tio, R.A. |
2010-03-01
|
|
Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome
(Article)
Pons, D. Monraats, P.S. Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Winter, R.J. de Tio, R.A. Waltenberger, J. Jukema, J.W. |
2009-07-31
|
|
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial
(Article)
Hirsch, A. Nijveldt, R. Biemond, B.J. Tijssen, J.G.P. Rossum, A.C. van Piek, J.J. Zijlstra, F.J. Vleuten, P.A. van der Tio, R.A. Giessen, W.J. van der Marques, K.M.J. Doevendans, P.A. Waltenberger, J. Berg, J.M. ten Aengevaeren, W.R.M. |
2008-02-05
|
|
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions
(Article)
Pons, D. Monraats, P.S. Winter, R.J. de Tio, R.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Maat, M.P.M. de Pires, N.M.M. Quax, P.H.A. Vlijmen, B.J.M. van Rosendaal, F.R. Zwinderman, A.H. Doevendans, P.A. Waltenberger, J. |
2007-12-01
|
|
Interleukin 10: A new risk marker for the development of restenosis after percutaneous coronary intervention
(Article)
Monraats, P.S. Kurreeman, F.A.S. Waltenberger, J. Huizinga, T.W.J. Eefting, D. Quax, P.H.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Pons, D. Sewgobind, V.D.K.D. Vries, F.R. de Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Winter, R.J. de Tio, R.A. |
2007-01-01
|
